These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37421781)

  • 1. Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma.
    Cao J; Du X; Zhao H; Zhu C; Li C; Zhang X; Wei L; Ke X
    Biomed Pharmacother; 2023 Sep; 165():115096. PubMed ID: 37421781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone, an agonist of PPARγ, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression.
    Higuchi T; Sugisawa N; Miyake K; Oshiro H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Kline Z; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Biomed Pharmacother; 2019 Oct; 118():109356. PubMed ID: 31545293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft.
    Natarajan A; Ramachandran B; Gopisetty G; Jayavelu S; Sundersingh S; Rajkumar T
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):361-371. PubMed ID: 33015747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
    Higuchi T; Yamamoto J; Sugisawa N; Tashiro Y; Nishino H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Genomics Proteomics; 2020; 17(1):35-40. PubMed ID: 31882549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
    Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.
    Ma H; He C; Cheng Y; Li D; Gong Y; Liu J; Tian H; Chen X
    Biomaterials; 2014 Oct; 35(30):8723-34. PubMed ID: 25017095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
    Yang Z; Liu J; Lu Y
    Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatinib ameliorates doxorubicin-induced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signalling.
    Tian ZC; Wang JQ; Ge H
    J Orthop Translat; 2020 May; 22():132-141. PubMed ID: 32440509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
    Cao J; Zhu C; Cao Z; Ke X
    Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable electrospun nanofibrous platform integrating antiplatelet therapy-chemotherapy for preventing postoperative tumor recurrence and metastasis.
    Li J; Li J; Yao Y; Yong T; Bie N; Wei Z; Li X; Li S; Qin J; Jia H; Du Q; Yang X; Gan L
    Theranostics; 2022; 12(7):3503-3517. PubMed ID: 35547751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable rhein-assisted crosslinked hydrogel for efficient local osteosarcoma chemotherapy.
    Zhang L; Liu YX; Yao YT; Zhou TJ; Jiang HL; Li CJ
    Int J Pharm; 2023 Mar; 634():122637. PubMed ID: 36702387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
    Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
    Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment.
    Yang Z; Yu S; Li D; Gong Y; Zang J; Liu J; Chen X
    Colloids Surf B Biointerfaces; 2018 Dec; 172():387-394. PubMed ID: 30193198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
    Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
    Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conductive gelatin methacrylamide hydrogel for synergistic therapy of osteosarcoma and potential bone regeneration.
    Liu X; Zhang Y; Wu H; Tang J; Zhou J; Zhao J; Wang S
    Int J Biol Macromol; 2023 Feb; 228():111-122. PubMed ID: 36563819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-Microsphere/IR820 Hybrid Bifunctional Hydrogels for In Situ Osteosarcoma Chemo-
    Tan B; Wu Y; Wu Y; Shi K; Han R; Li Y; Qian Z; Liao J
    ACS Appl Mater Interfaces; 2021 Jul; 13(27):31542-31553. PubMed ID: 34191477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of adriamycin gelatin microsphere-loaded decellularized periosteum that is cytotoxic to human osteosarcoma cells.
    Chen C; Dong J; Chen H; Wang X; Mei J; Wang L; Xian CJ
    J Cell Physiol; 2019 Jul; 234(7):10771-10781. PubMed ID: 30480804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.